Polycystic Kidney Disease Treatment Network

horizontal rule

HALT PKD

horizontal rule

HALT PKD Clinical Research

The Polycystic Kidney Disease Treatment Network (PKD-TN) has established the HALT PKD clinical trials to test interventions that may be effective in slowing kidney growth in patients suffering from polycystic kidney disease.  Top investigators from a number of leading United States medical centers, with full support from the NIH National Institute of Diabetes & Digestive & Kidney Diseases, are collaborating in HALT PKD clinical trials.  The Division of Biostatistics at Washington University in St. Louis served as the Data Coordinating Center (DCC) through June 30, 2009, under the guidance of Professor J. Philip Miller, and was responsible for developing the data entry system, managing all study data, tracking patient recruitment and adverse events, and overseeing data collection and reporting. The responsibilities of the HALT PKD Data Coordinating Center were transferred to the University of Pittsburgh Medical Center on July 1, 2009.
 

bullet Beth Israel Deaconess Medical Center
 
bullet Cleveland Clinic Foundation
 
bullet Emory University
 
bullet Mayo Clinic
 
bullet Tufts Medical Center
 
bullet University of Colorado Health Sciences Center
 
bullet University of Kansas Medical Center
 
bullet Washington University in St. Louis


*Please note that final determination of eligibility to participate in any clinical trial requires that the principal investigator or his/her designate make a very subject-specific, case-by-case assessment based on defined inclusion/exclusion criteria.
 

Resources for Information on HALT PKD and Polycystic Kidney Disease

bulletHALT PKD: ClinicalTrials.gov

Information on the specific aims of the HALT PKD study, the eligibility requirements for study participation, and the individuals to contact if you are interested in being considered for the study, may be found at ClinicalTrials.gov, a website sponsored by the U.S. National Institutes of Health (NIH) to link patients to medical research.
 
bulletPKD Foundation

The PKD Foundation is the only organization, worldwide, devoted to determining the cause, improving clinical treatment and discovering a cure for Polycystic Kidney Disease (PKD).
 
bullet Clinical Trials Update
 
bullet U.S. National Institute of Diabetes & Digestive & Kidney Diseases of the National Institutes of Health
 
bullet RFA - Ancillary Studies to Major Ongoing NIDDK and NHLBI Clinical Research Studies (R01)

 

Participate recruitment to HALT PKD has been completed.

bulletFor information on the current status of the HALT PKD clinical trials, please email the Project Manager, Patty Smith, at the University of Pittsburgh Medical Center. You can also reach her by phone at (412) 692-2490.
 
bulletInformation on study participation may be found by referring to the HALT PKD study brochure - just click on the link below:.
 
bullet HALT PKD Study Brochure (pdf)

           

 
bulletHALT PKD: Information for Physicians Brochure (pdf)
 
bulletStudy participants are followed at 1 of 7 participating clinic sites, assigned according to the state in which they live.
 

Participants from these Eastern states are followed at Tufts Medical Center or Beth Israel Deaconess Medical Center:

Connecticut, Delaware, District of Columbia, Maine, Maryland, Massachusetts, Pennsylvania, New Hampshire, New Jersey, New York, Rhode Island, Vermont, or Virginia - please call:

Tufts Medical Center – Boston, MA
1-866-846-2735
(toll-free)

Beth Israel Deaconess Medical Center – Boston, MA
1-866-650-1815 (toll-free)

Participants from these Southern states are followed at Emory University:

Alabama, Florida, Georgia, Louisiana, Mississippi, North Carolina, South Carolina, or Tennessee - please call:

Emory University – Atlanta, Georgia
1-404-686-8280

Participants from these Midwestern states are followed at Mayo Clinic, Cleveland Clinic, or Kansas University Medical Center:

Arkansas, Iowa, Illinois, Indiana, Kansas, Kentucky, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, Oklahoma, South Dakota, West Virginia, or Wisconsin - please call:

Mayo Clinic – Rochester, Minnesota
1-888-630-2616
(toll-free)

Cleveland Clinic Foundation – Cleveland, Ohio
1-800-223-2273, Ext. 44680 (toll-free)

Kansas University Medical Center – Kansas City, Kansas
1-913-588-7609

Participants from these Western states are followed at the University of Colorado:

Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Texas, Utah, Washington, or Wyoming - please call:

University of Colorado Health Sciences Center
Denver, Colorado
1-877-765-9297 (toll-free)

horizontal rule

Portions of the PKD-TN web site can be
accessed only by authorized study investigators.

To apply for authorization to access user-restricted sections of the
PKD-TN/HALT PKD Web Site, please download
Form #A-1 (Word Document).

Investigator Log-In   °   DSMB Log-In

Manual of Procedures (html)   °   Manual of Procedures (pdf)

Web Data Entry System   °   Web-Based Reports

Data Coordinating Center   °   DCC Sidedoor

horizontal rule

Hosted by
Washington University in St. Louis - School of Medicine
Division of Biostatistics

Last updated: 09/25/09.